Bioform Medical (NASDAQ:BFRM)
| CAPS Rating |
|
|---|---|
| Open | $0.00 |
| Previous Close | $5.44 |
| Daily Range | $5.44 - $5.46 |
| 52-Week Range | $0.88 - $5.70 |
| Market Cap | $257.03M |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 0 |
| Average Daily Volume | 0 |
BFRM
VS S&P 500 (SPY)
How do you think BFRM will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
BFRM Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
Related News and Articles
- Modified Study, Same Bloody Results – The Motley Fool
- Buy, Sell, or Hold: Ariad Pharmaceuticals – The Motley Fool
- Why Did My Stock Just Die? – The Motley Fool
- Merck Investors Can Sleep Easier (Not Easy) – The Motley Fool
- Is This Situation Special Enough? – The Motley Fool
- Investments for Income Lovers – The Motley Fool
- The Highest-Yielding Dow Stocks – The Motley Fool
- Dividend Stocks You Need to Watch Today – The Motley Fool
- 3 Stocks on Our Radar – The Motley Fool
- Curing Diseases Makes For a Bad Business Model – The Motley Fool
- This Just In: Upgrades and Downgrades – The Motley Fool
- Has Elan Become the Perfect Stock? – The Motley Fool
- 1 Cheap Biotech Small-Cap With Huge Potential – The Motley Fool
- The Disadvantage of a Successful Pipeline – The Motley Fool
- Side Effect of Low Side Effects: 20% Stock Gain – The Motley Fool
- This Drug Approval Is Good For the Industry – The Motley Fool
- Lipitor Loss? What's That? – The Motley Fool
- Kidney Cancer? There's a Drug for That – The Motley Fool
- FDA Approval Isn't Enough – The Motley Fool
- UPS Preps for Share Buybacks – The Motley Fool
RSS Headlines
Fool UK
